GO:0006356 regulation of transcription by RNA polymerase I: Ribosome Biogenesis Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006356 describes any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase I, the enzyme dedicated to ribosomal RNA synthesis.
• RNA polymerase I transcription is the rate-limiting step for ribosome biogenesis and therefore controls cell growth, proliferation, and biomass accumulation.
• The process is regulated by a dedicated set of transcription factors including SL1, UBF, TAF1, and RRN3, which respond to growth signaling and nutrient cues.
• Dysregulation of RNA polymerase I transcription is a hallmark of cancer and is also implicated in developmental disorders and aging.
• MYC and mTOR are major upstream regulators that coordinate RNA polymerase I activity with cell growth and metabolism.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of RNA polymerase I regulatory networks.
Description
Regulation of transcription by RNA polymerase I (GO:0006356) is the biological process that controls the synthesis of ribosomal RNA (rRNA) by RNA polymerase I (Pol I). This process is fundamental because rRNA constitutes the structural and catalytic core of the ribosome, and its production is tightly coupled to cell growth, proliferation, and metabolic status. Unlike mRNA transcription by RNA polymerase II, Pol I transcription occurs exclusively in the nucleolus and is dedicated to the large ribosomal RNA precursor. The rate of Pol I transcription directly determines the cell's capacity for protein synthesis and is therefore a critical node in growth control. The importance of GO:0006356 extends beyond basic cell biology. In cancer, hyperactivation of Pol I transcription is a common feature that supports the elevated protein synthesis demands of rapidly dividing cells. In developmental disorders and aging, altered Pol I activity contributes to cellular senescence and organismal decline. In trypanosomes, Pol I transcription is uniquely used for protein-coding genes, illustrating evolutionary diversity in this process. Understanding the molecular players and regulatory mechanisms of GO:0006356 is therefore essential for researchers in cell biology, cancer, and developmental biology. This article provides a research-grade overview of GO:0006356, integrating the QuickGO definition with verified PubMed literature. It covers the core molecular machinery, key genes, disease links, and modern research methods including CRISPR-based models. All factual statements are supported by real citations to guide experimental design and generative-AI retrieval.
regulation of transcription by RNA polymerase I At A Glance
| GO ID | GO:0006356 |
|---|---|
| GO term | regulation of transcription by RNA polymerase I |
| Ontology | biological_process |
| Synonym | regulation of transcription from Pol I promoter; regulation of transcription from RNA polymerase I promoter |
| Major function | Controls the rate of ribosomal RNA synthesis, thereby regulating ribosome biogenesis and cell growth |
| Cellular location | Nucleolus (rDNA loci) |
| Key enzyme | RNA polymerase I (Pol I) |
| Major regulators | SL1, UBF, TAF1, RRN3, MYC, mTOR |
| Disease relevance | Cancer, developmental disorders, aging, ribosomopathies |
What Is GO:0006356?
GO:0006356, regulation of transcription by RNA polymerase I, is defined by QuickGO as any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase I. In other words, it encompasses all molecular events that control how often and how efficiently RNA polymerase I initiates and elongates rRNA transcripts from ribosomal DNA (rDNA) promoters. This includes the assembly of the Pol I pre-initiation complex, the action of Pol I-specific transcription factors, and the signaling pathways that adjust Pol I activity in response to growth and stress cues.
Why Is regulation of transcription by RNA polymerase I Important in Cell Biology?
GO:0006356 is important because it governs the first and rate-limiting step of ribosome biogenesis, which is required for all protein synthesis and cell growth. Dysregulation of Pol I transcription is directly linked to cancer, where oncogenes such as MYC drive excessive rRNA synthesis to support proliferation. Moreover, Pol I transcription is a target of aging-related signaling and is implicated in developmental disorders, making it a central node in both normal physiology and disease.
• Controls ribosome biogenesis and global protein synthesis capacity.
• Rate-limiting for cell growth and proliferation.
• Hyperactivated in many cancers, including MYC-driven tumors.
• Involved in developmental disorders and ribosomopathies.
• Linked to aging and cellular senescence.
• Target of mTOR and MYC signaling pathways.
• Essential for trypanosome viability due to unique Pol I transcription of protein-coding genes.
• Provides a therapeutic target for cancer and growth disorders.
• Requires coordinated regulation of Pol I core subunits such as RPA12.
• Studied using CRISPR knockout, knock-in, and overexpression models.
What Happens During regulation of transcription by RNA polymerase I?
Initiation complex assembly at the rDNA promoter
In simple terms: First, a group of proteins must gather on the DNA to tell RNA polymerase I where to start.
Regulation of Pol I transcription begins with the assembly of a pre-initiation complex at the ribosomal DNA promoter. In mammals, this involves the selectivity factor SL1 (TBP-TAF1 complex) and the upstream binding factor UBF, which bind to the rDNA promoter and recruit Pol I. The initiation factor RRN3 (TIF-IA) associates with Pol I and is essential for recruitment to the promoter. This step is highly regulated and determines the overall rate of rRNA synthesis.
Elongation and rRNA processing
In simple terms: Once started, the polymerase moves along the DNA to make a long rRNA transcript that is later cut into pieces.
After initiation, Pol I elongates the 47S pre-rRNA transcript, which is subsequently processed into mature 18S, 5.8S, and 28S rRNAs. Elongation is coupled with co-transcriptional processing and assembly of ribosomal subunits. Regulation of elongation can also occur through factors that modify Pol I processivity.
Growth factor and nutrient signaling
In simple terms: External signals like growth factors tell the cell whether to make more ribosomes.
Pol I transcription is regulated by growth factor and nutrient signaling pathways. mTOR and MYC are key upstream regulators that stimulate Pol I activity in response to growth signals. Conversely, stress and nutrient deprivation inhibit Pol I transcription through mechanisms involving RRN3 phosphorylation and SL1 modification.
Feedback and quality control
In simple terms: The cell monitors rRNA production and adjusts it to match need.
Feedback mechanisms ensure that rRNA synthesis is balanced with ribosomal protein availability. Disruption of Pol I core subunits, such as RPA12, can alter the expression of other Pol I subunits, indicating autoregulatory loops. Quality control pathways degrade excess or aberrant rRNA to maintain cellular homeostasis.
Key Genes Involved in GO:0006356 regulation of transcription by RNA polymerase I
The following genes and proteins are central to the regulation of transcription by RNA polymerase I (GO:0006356), based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| POLR1A | Catalytic subunit of RNA polymerase I | Core enzyme for rRNA synthesis; knockout lethal |
| POLR1B | Second largest subunit of Pol I | Essential for Pol I assembly and activity |
| POLR1C | Shared subunit of Pol I and Pol III | Mutations linked to Treacher Collins syndrome |
| POLR1D | Shared subunit of Pol I and Pol III | Mutations linked to Treacher Collins syndrome |
| RPA12 | Pol I subunit; influences core subunit expression | Regulates Pol I core protein levels |
| RRN3 | Essential initiation factor for Pol I | Target of mTOR signaling; regulates Pol I recruitment |
| SL1 (TBP-TAF1) | Selectivity factor for Pol I promoter | Determines species-specific rDNA promoter recognition |
| UBF | Upstream binding factor; architectural transcription factor | Activates rDNA transcription; marker of nucleolar organizer regions |
| TAF1 | TBP-associated factor in SL1 | Essential for SL1 function and Pol I initiation |
| MYC | Oncogenic transcription factor | Drives Pol I and Pol III transcription in cancer |
| mTOR | Serine/threonine kinase | Activates Pol I transcription via RRN3 |
| PTEN | Tumor suppressor; inhibits PI3K/AKT/mTOR | Loss leads to Pol I hyperactivation |
| RB1 | Tumor suppressor | Represses Pol I transcription via interaction with UBF |
| p53 | Tumor suppressor | Inhibits Pol I transcription under stress |
| CDK1 | Cell cycle kinase | Phosphorylates Pol I factors during mitosis |
| CK2 | Protein kinase | Phosphorylates UBF and regulates Pol I activity |
| SIRT1 | NAD-dependent deacetylase | Modulates Pol I transcription in aging |
| AMPK | Energy sensor kinase | Inhibits Pol I transcription under low energy |
How Is regulation of transcription by RNA polymerase I Regulated?
Regulation of transcription by RNA polymerase I is controlled by multiple signaling pathways. The mTOR pathway integrates growth factor and nutrient signals to activate Pol I transcription, primarily through phosphorylation of RRN3 and SL1 components. MYC directly stimulates Pol I and Pol III transcription to support cell growth. Tumor suppressors such as p53, RB1, and PTEN negatively regulate Pol I transcription, and their loss leads to hyperactivation. Additionally, AMPK and SIRT1 mediate metabolic and aging-related repression of Pol I activity. These regulatory layers ensure that rRNA synthesis matches cellular demand.
regulation of transcription by RNA polymerase I and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MYC | Cancer (MYC-driven tumors) | Knockout or overexpression in cancer cell lines |
| POLR1C | Treacher Collins syndrome | Point mutation knock-in in iPSCs |
| POLR1D | Treacher Collins syndrome | Knockout in zebrafish or mouse models |
| RRN3 | Cancer, growth disorders | Knockout and rescue with phospho-mutants |
| p53 | Cancer, stress response | Knockout in cancer cells to study Pol I derepression |
Cancer
Hyperactivation of RNA polymerase I transcription is a common feature of cancer cells, supporting the increased protein synthesis required for rapid proliferation. Oncogenes such as MYC drive Pol I transcription, while tumor suppressors like p53 and RB1 restrain it. Targeting Pol I transcription is an emerging therapeutic strategy in oncology.
Developmental disorders and ribosomopathies
Mutations in Pol I subunits and assembly factors cause ribosomopathies such as Treacher Collins syndrome, characterized by craniofacial defects and developmental abnormalities. These disorders highlight the critical role of Pol I transcription in normal development.
Aging and neurodegeneration
Altered Pol I transcription is associated with aging and age-related diseases. SIRT1 and AMPK signaling repress Pol I activity under caloric restriction, promoting longevity. In neurodegeneration, nucleolar stress and impaired rRNA synthesis contribute to neuronal dysfunction.
From regulation of transcription by RNA polymerase I-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is POLR1A essential for cell viability? | CRISPR knockout in human cell lines |
| Does a specific point mutation in POLR1C cause Treacher Collins syndrome? | Point mutation knock-in in iPSCs |
| How does RRN3 phosphorylation affect Pol I recruitment? | Knock-in of phospho-deficient or phospho-mimetic RRN3 |
| What is the effect of MYC overexpression on Pol I transcription? | Overexpression of MYC in cancer cell lines |
| Can tagging Pol I subunits reveal their dynamics? | Tagged knock-in of POLR1A with fluorescent protein |
| What genes regulate Pol I transcription? | CRISPR library screening for modifiers of rRNA synthesis |
How to Study the regulation of transcription by RNA polymerase I Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 3H-uridine labeling | Rate of rRNA synthesis | Assessing Pol I activity under growth conditions |
| qPCR of pre-rRNA | Steady-state levels of rRNA precursors | Screening for regulators of Pol I transcription |
| ChIP | Occupancy of Pol I and factors at rDNA | Studying initiation complex assembly |
| Proteomics | Protein interactions and modifications | Identifying novel Pol I regulators |
| Live-cell imaging | Dynamics of Pol I subunits | Visualizing transcription in real time |
| CRISPR knockout | Gene function | Testing essentiality of Pol I genes |
| CRISPR knock-in | Tagged or mutant protein expression | Studying point mutations and localization |
| RNA-seq | Global transcriptome changes | Assessing downstream effects of Pol I perturbation |
Measuring rRNA synthesis
rRNA synthesis can be measured by metabolic labeling with 3H-uridine or by quantitative PCR of pre-rRNA transcripts. These methods quantify the rate of Pol I transcription and are used to assess regulatory effects.
Chromatin immunoprecipitation (ChIP)
ChIP with antibodies against Pol I subunits or transcription factors (e.g., UBF, SL1) measures their occupancy at rDNA promoters, revealing initiation complex assembly.
Proteomics and interactomics
Mass spectrometry-based proteomics identifies Pol I-associated proteins and post-translational modifications, providing insights into regulatory complexes.
Live-cell imaging
Fluorescent tagging of Pol I subunits or rDNA loci enables real-time visualization of transcription dynamics in living cells.
How CRISPR Can Be Used to Study GO:0006356 regulation of transcription by RNA polymerase I
Knockout
CRISPR knockout of Pol I subunits such as POLR1A or POLR1B is lethal, confirming their essential role in rRNA synthesis. Conditional knockout models allow tissue-specific study of Pol I function in development and disease.
Point Mutation
Point mutations in Pol I subunits or regulators can be introduced by CRISPR to model human diseases such as Treacher Collins syndrome or to dissect phosphorylation sites in RRN3.
Knock-in
Knock-in of fluorescent or epitope tags into endogenous Pol I genes enables live-cell imaging and proteomic analysis of native complexes.
Overexpression
CRISPR activation or cDNA overexpression of MYC or RRN3 can drive Pol I hyperactivation, modeling cancer-associated states.
How EDITGENE Supports regulation of transcription by RNA polymerase I Research
Researchers studying regulation of transcription by RNA polymerase I-related genes often need to determine whether a candidate gene is causally involved in rRNA synthesis, cell growth, or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for regulation of transcription by RNA polymerase I research.
Frequently Asked Questions About regulation of transcription by RNA polymerase I
What is GO:0006356?
GO:0006356 is the Gene Ontology term for regulation of transcription by RNA polymerase I, defined as any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase I.
What genes are involved in regulation of transcription by RNA polymerase I?
Key genes include POLR1A, POLR1B, POLR1C, POLR1D, RRN3, SL1 (TBP-TAF1), UBF, MYC, and mTOR.
Why is RNA polymerase I transcription important for cancer?
Cancer cells often hyperactivate Pol I transcription to support rapid growth, and oncogenes like MYC drive this process.
How is RNA polymerase I transcription regulated?
It is regulated by growth signaling pathways including mTOR and MYC, as well as tumor suppressors like p53 and RB1.
What diseases are linked to defects in RNA polymerase I transcription?
Diseases include cancer, Treacher Collins syndrome, other ribosomopathies, and aging-related disorders.
What methods are used to study regulation of transcription by RNA polymerase I?
Common methods include 3H-uridine labeling, qPCR of pre-rRNA, ChIP, proteomics, and live-cell imaging.
Can CRISPR be used to study RNA polymerase I transcription?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models are widely used to dissect Pol I regulatory networks.
What is the role of RRN3 in Pol I transcription?
RRN3 is an essential initiation factor that recruits Pol I to the promoter and is regulated by mTOR signaling.
How does MYC regulate RNA polymerase I transcription?
MYC directly stimulates Pol I transcription and also regulates Pol III, coordinating ribosome biogenesis with cell growth.
What is the clinical relevance of Pol I transcription inhibitors?
Pol I transcription inhibitors are being developed as anticancer agents because they selectively target rapidly proliferating cells.
Conclusion
Regulation of transcription by RNA polymerase I (GO:0006356) is a fundamental biological process that controls ribosome biogenesis and cell growth. Its dysregulation is implicated in cancer, developmental disorders, and aging, making it a key research area. Understanding the molecular mechanisms and regulatory networks of Pol I transcription provides opportunities for therapeutic intervention. EDITGENE offers comprehensive CRISPR services to support mechanistic studies and disease modeling in this field.
References
- 1. Sharifi S et al.. 2018. Regulation of RNA Polymerase I Transcription in Development, Disease, and Aging.. Annu Rev Biochem 87:51-73 PMID: 29589958
- 2. Grummt I. 1999. Regulation of mammalian ribosomal gene transcription by RNA polymerase I.. Prog Nucleic Acid Res Mol Biol 62:109-54 PMID: 9932453
- 4. Lee MG et al.. 1997. Transcription of protein-coding genes in trypanosomes by RNA polymerase I.. Annu Rev Microbiol 51:463-89 PMID: 9343357
- 5. Ford BL et al.. 2023. Expression of RNA polymerase I catalytic core is influenced by RPA12.. PLoS One 18(5):e0285660 PMID: 37167337
- 6. Campbell KJ et al.. 2014. MYC regulation of cell growth through control of transcription by RNA polymerases I and III.. Cold Spring Harb Perspect Med 4(5) PMID: 24789877
- 7. Scull CE et al.. 2019. Coordinated Control of rRNA Processing by RNA Polymerase I.. Trends Genet 35(10):724-733 PMID: 31358304
- 8. Hannan KM et al.. 1998. Transcription by RNA polymerase I.. Front Biosci 3:d376-98 PMID: 9514985
